LLY vs MAR: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Marriott International, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Eli Lilly and Company · Healthcare
$1,179.09
+31.7% upside to fair value
High Conviction
Grade A
High Quality
VS
Marriott International, Inc. · Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
LLY has more upside to fair value
(+31.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
MAR |
| Current Price |
$1,179.09 |
$366.24 |
| Fair Value Estimate |
$1,552.32 |
$353.64 |
| Upside to Fair Value |
+31.7%
|
-3.4%
|
| Market Cap |
$1,110.4B |
$96.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
34.3x
|
23.8x
|
| Price / Sales |
14.6x
|
3.7x
|
| Price / FCF |
77.7x
|
31.6x
|
| Revenue Growth YoY |
+55.5%
|
+6.2%
|
| Gross Margin |
83.5%
|
21.4%
|
| Operating Margin |
45.9%
|
16.0%
|
| Return on Equity |
101.3%
|
-74.1%
|
| Dividend Yield |
0.55% |
0.75% |
| FCF Yield |
1.29%
|
3.17%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Eli Lilly is a global biopharma company whose exceptionally profitable cardiometabolic franchises, led by Mounjaro and Zepbound, are driving a high-quality growth phase: revenue rose 55.5% year over year and earnings rose 168.0% year over year in the most recent quarter, while gross, operating, and net margins were 83.5%, 45.9%, and 35.0%, respectively. Business quality is high because tirzepatid…
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
Accumulation Zones
| Metric |
LLY |
MAR |
| Zone Low |
$1,164.24 |
$265.23 |
| Zone High |
$1,319.47 |
$300.59 |
| In Buy Zone? |
Yes
|
No
|